In the Boardroom
Refine Search
Pharmaceutical
Danish allergy specialist ALK-Abello has appointed Helle Skov as new Executive Vice President (Product Supply) and member of the Board of Management of ALK-Abelló A/S. 1 July 2014
Pharmaceutical
UK drug discovery firm Summit, which is focused on therapies for Duchenne muscular dystrophy and Clostridium difficile infection, has established US operations in Cambridge, Massachusetts. 17 June 2014
Pharmaceutical
Up to 2022, Danish diabetes care giant Novo Nordisk expects to hire 6,000 new employees in Denmark, half of whom will work within research and development. The new jobs will have the derived effect of boosting employment by more than 15,000 jobs nationally. 11 June 2014
Pharmaceutical
Dieter Weinand will become President of the HealthCare division of German pharma major Bayer Pharmaceuticals, effective August 1, 2014 and at the same time join the Executive Committee of Bayer HealthCare. 5 June 2014
Pharmaceutical
Australia/USA-based Spinifex Pharmaceuticals, a pain drug development company, has announced the appointment of Ronald Marcus as Chief Medical Officer. 5 June 2014
Pharmaceutical
There were a couple of surprise planned departures and relocations revealed at European pharmaceutical majors, first at Germany’s Bayer and also at France’s Sanofi. 4 June 2014
Pharmaceutical
Israel-based Teva Pharmaceutical Industries has announced changes in its senior leadership team. 3 June 2014
Pharmaceutical
Swiss pharma major Novartis has announced the appointment of Bruno Strigini as president of Novartis Oncology, effective June 1, replacing Herve Hoppenot, who quit the post early this year to become chief executive of USA-based Incyte Corp. 1 June 2014
Pharmaceutical
US pharma giant Pfizer has announced that Morris Birnbaum has joined the company as Chief Scientific Officer for Cardiovascular and Metabolic Disease Research. Dr Birnbaum will report directly to Rod MacKenzie, Group Senior Vice President and Head of PharmaTherapeutics Research & Development. 30 May 2014
Pharmaceutical
US drugmaker AbbVie (NYSE: ABBV) has named Michael Severino as Executive Vice President, Research and Development (R&D) and Chief Scientific Officer. 16 May 2014
Pharmaceutical
The Supervisory Board of Merck has elected Wolfgang Büchele as Chairman of its corporate governance body. 12 May 2014
Pharmaceutical
Germany’s Merck (MRK: DE) has appointed Marcus Kuhnert as Group Chief Financial Officer. Mr Kuhnert will become a member of Merck’s Executive Board with unlimited personal liability as of August 1, 2014. 9 May 2014
Pharmaceutical
Italian pharmaceutical company Menarini Group has announced that previous manager Dr Alberto Sergio Aleotti has passed away. 8 May 2014
Pharmaceutical
UK-based GW Pharmaceuticals has announced the appointment of Kenneth Sommerville to the newly created position of VP, Clinical Science, based in the USA. 7 May 2014
Pharmaceutical
US-based pharmacogenetics company Millennium Laboratories has announced the appointment of Nikhil Nayak as chief marketing officer, Steven Soe as chief compliance officer, and Michael Flowers as vice president, government operations. 6 May 2014
Pharmaceutical
Japanese drug major Astellas Pharma has announced the promotions of Bernhardt Zeiher to executive vice president, Global Development and Jeannette Barrett to vice president and head of Medical Excellence, Global Medical Affairs. 6 May 2014
Pharmaceutical
Australia-based QRxPharma has announced the appointment of Edward Rudnic as Chief Executive Officer with immediate effect. 2 May 2014
Pharmaceutical
Chugai Pharma USA (CPUSA) has announced the appointment of Athos Gianella-Borradori as Chief Medical Officer. 25 April 2014
Pharmaceutical
Pharma major Lupin has announced the appointment of Theresa Stevens as Chief Corporate Development Officer for its global operations. 23 April 2014
Pharmaceutical
Japanese drugmaker Daiichi Sankyo has announced that Ken Keller will join the company as President of its Commercial operations in the United States. 23 April 2014
Pharmaceutical
UK-based NeoPhore Limited, a small molecule neoantigen immuno-oncology company, today announced the appointment of Michael Shih as chief executive (CEO) and to the board of directors, effective immediately. 16 December 2024
Pharmaceutical
US antivirals major Gilead Sciences announced that Dr Dietmar Berger will join the company on January 2, 2025, as chief medical officer (CMO) and will become a member of Gilead’s senior leadership team. Dr Berger succeeds Dr Merdad Parsey. 13 December 2024
Pharmaceutical
AstraZeneca has brought in Iskra Reic to replace Leon Wang, who is on extended leave from the Anglo-Swedish drugmaker while under investigation in China. 4 December 2024
Pharmaceutical
Bausch Health Bausch Health (NYSE/TSX: BHC) has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. has appointed Dr Jonathan Sadeh as executive vice president, chief medical officer and head of R&D. 3 December 2024
Pharmaceutical
Germany’s Evotec has said its chief operating officer Craig Johnstone will leave the business at the end of the year. 29 November 2024
Pharmaceutical
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced that Dr Thomas Schinecker, chief executive (CEO) of Swiss pharma giant Roche (ROG: SIX), will take up the post as president of the trade association effective January 1, 2025. 26 November 2024
Pharmaceutical
Specialist pre-clinical contract research organization (CRO) and ion channel screening company Metrion Biosciences has announced the appointment of Lee Patterson as its new chief executive. 25 November 2024
Pharmaceutical
Anthony Harnden has been appointed as the new chair of the UK’s Medicine and Healthcare products Regulatory Agency (MHRA). 20 November 2024
Pharmaceutical
New York-based Mind Medicine, a company developing MM120, a form of LSD (lysergide d-tartrate), for mental health conditions, has announced the appointment of Gregg Pratt, as chief regulatory and quality assurance officer. 19 November 2024
Pharmaceutical
US ophthalmology specialist Ocular Therapeutix announced that Namrata Saroj has joined the Company on a full-time basis as chief business officer (CBO). Dr Saroj previously served as development strategy consultant to Ocular since February 2024. 14 November 2024
Pharmaceutical
Fennec Pharmaceuticals has announced the addition of three new executives to bolster its leadership team as the company prepares for expanded commercial operations. 28 October 2024
Pharmaceutical
British artificial intelligence specialist BenevolentAI has announced the return of its founder, Ken Mulvany, as executive chairman. 18 October 2024
Pharmaceutical
Canada-based biotech Sernova (TSX: SVA) has announced key new appointments to its executive leadership team. 15 October 2024
Pharmaceutical
Cancer start-up Black Diamond Therapeutics has announced a significant restructuring as part of its plan to focus resources on its lead drug, BDTX-1535. 10 October 2024
Pharmaceutical
US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country president. 7 October 2024
Pharmaceutical
ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of Nicholas Ostrout, as vice president of corporate development and strategy. 7 October 2024
Pharmaceutical
Nxera Pharma has entered a new commercial partnership agreement with fellow Japanese drugmaker Shionogi regarding the distribution and sales for Quviviq (daridorexant 25 and 50mg) in Japan. 1 October 2024
Pharmaceutical
Privately-held German pain specialist Grünenthal has appointed Jan Adams its new chief commercial officer (CCO) and a member of the corporate executive board. 30 September 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze